Close Menu

NEW YORK (GenomeWeb) – Waters reported today that its first quarter revenues fell 3 percent year over year, as the company saw weak sales in China and Europe and within its TA instruments division.

Waters posted revenues of $513.9 million for the quarter compared to $530.7 million in Q1 2018, below the average Wall Street estimate of $545.3 million.

Currency translation decreased sales growth by around 3 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.